Diagnostic methods for fungal infections in pediatric patients: Microbiological, serological and molecular methods

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 3, 2011, Pages 289-298

  Oz, Yasemin ^a   Kiraz, Nuri ^b  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

glucan; Aspergillus; Candida; diagnosis; galactomannan; pediatric

Indexed keywords

BETA 1,3 GLUCAN; FUNGUS ANTIGEN; GALACTOMANNAN; MANNAN;

ANTIGEN DETECTION; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; FUNGAL DETECTION; FUNGUS CULTURE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MOLECULAR DIAGNOSIS; POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; SYSTEMIC MYCOSIS;

ASPERGILLOSIS; ASPERGILLUS; BETA-GLUCANS; CANDIDA; CANDIDIASIS, INVASIVE; CHILD; CULTURE TECHNIQUES; DIAGNOSTIC TECHNIQUES AND PROCEDURES; EARLY DIAGNOSIS; HUMANS; MANNANS; SENSITIVITY AND SPECIFICITY;

EID: 79952927279     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.168     Document Type: Review

References (82)

1. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology (6th Edition). Elsevier Mosby, Philadelphia, PA, USA (2009).
2. Hovi L, Saxen H, Saarinen-Pihkala UM, Vettenranta K, Meri T, Richardson M. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders. Pediatr. Blood Cancer 48, 28-34 (2007). (Pubitemid 44871589)
3. Steinbach WJ, Addison RM, McLaughlin L et al. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr. Infect. Dis. J. 26, 558-564 (2007) (Pubitemid 47014154)
4. Castagnola E, Conte M, Parodi S, Papio F, Caviglia I, Haupt R. Incidence of bacteremias and invasive mycoses in children with high risk neuroblastoma. Pediatr. Blood Cancer 49, 672-677 (2007). (Pubitemid 350194433)
5. Castagnola E, Bagnasco F, Faraci M et al. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience. Bone Marrow Transplant. 41, 339-347 (2008). (Pubitemid 351330728)
6. Castagnola E, Rossi MR, Cesaro S et al. Incidence of bacteremias and invasive mycoses in children with acute nonlymphoblastic leukemia: results from a multi-center Italian study. Pediatr. Blood Cancer 55, 1103-1107 (2010).
7. Urrea M, Pons M, Serra M, Latorre C, Palomeque A. Prospective incidence study of nosocomial infections in a pediatric intensive care unit. Pediatr. Infect. Dis. J. 22, 490-494 (2003).
8. Sung L, Lange BJ, Gerbing RB, Alonzo TA, Feusner J. Microbiologically documented infections and infectionrelated mortality in children with acute myeloid leukemia. Blood 110, 3532-3539 (2007). (Pubitemid 350159617)
9. Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr. Radiol. 33, 453-460 (2003). (Pubitemid 36833728)
10. Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn. Microbiol. Infect. Dis. 17, 103-109 (1993). (Pubitemid 23294544)
11. Arendrup MC, Bergmann OJ, Larsson L, Nielsen HV, Jarløv JO, Christensson B. Detection of candidaemia in patients with and without underlying haematological disease. Clin. Microbiol. Infect. 16, 855-862 (2010).
12. Duthie R, Denning DW. Aspergillus fungemia: report of two cases and review. Clin. Infect. Dis. 20, 598-605 (1995).
13. Kahn FW, Jones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am. J. Clin. Pathol. 86, 518-523 (1986). (Pubitemid 16006882)
14. Ellepola AN, Morrison CJ. Laboratory diagnosis of invasive candidiasis. J. Microbiol. 43, 65-84 (2005). (Pubitemid 40431503)
15. Horvath LL, George BJ, Murray CK, Harrison LS, Hospenthal DR. Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for Candida growth detection. J. Clin. Microbiol. 42, 115-118 (2004). (Pubitemid 38082707)
16. Klont RR, Mennink-Kersten MA, Verweij PE. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin. Infect. Dis. 39, 1467-1474 (2004). (Pubitemid 39518210)
17. Maertens JA, Klont R, Masson C et al. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin. Infect. Dis. 44, 1329-1336 (2007). (Pubitemid 46729195)
18. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin. Infect. Dis. 42, 1417-1727 (2006).
19. Wheat LJ, Walsh TJ. Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. Eur. J. Clin. Microbiol. Infect. Dis. 27, 245-251 (2008).
20. Herbrecht R, Letscher-Bru V, Oprea C et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J. Clin. Oncol. 20, 1898-1906 (2002). (Pubitemid 34273282)
21. Hayden R, Pounds S, Knapp K et al. Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis. Pediatr. Infect. Dis. J. 27, 815-819 (2008).
22. Castagnola E, Furfaro E, Caviglia I et al. Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation. Clin. Microbiol. Infect. 16, 1197-1203 (2010).
23. Armenian SH, Nash KA, Kapoor N et al. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients. J. Pediatr. Hematol. Oncol. 31, 920-926 (2009).
24. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J. Infect. Dis. 190, 641-649 (2004). (Pubitemid 38982107)
25. Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 91, 311-318 (2001). (Pubitemid 32099231)
26. Mennink-Kersten MA, Ruegebrink D, Klont RR et al. Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity. J. Clin. Microbiol. 43, 3925-3931 (2005). (Pubitemid 41129682)
27. Sulahian A, Touratier S, Ribaud P. False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N. Engl. J. Med. 349, 2366-2367 (2003). (Pubitemid 37509754)
28. Orlopp K, von Lilienfeld-Toal M, Marklein G et al. False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem? J. Antimicrob. Chemother. 62, 1109-1112 (2008).
29. Aubry A, Porcher R, Bottero J et al. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with b-lactam antibiotics in patients with hematological disorders. J. Clin. Microbiol. 44, 389-394 (2006). (Pubitemid 43222228)
30. Mori Y, Nagasaki Y, Kamezaki K et al. High incidence of false-positive Aspergillus galactomannan test in multiple myeloma. Am. J. Hematol. 85, 449-451 (2010).
31. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin. Infect. Dis. 40, 1762-1769 (2005). (Pubitemid 40799945)
32. Husain S, Clancy CJ, Nguyen MH et al. Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. Clin. Vaccine Immunol. 15, 1760-1763 (2008).
33. Nguyen MH, Jaber R, Leather HL et al. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts. J. Clin. Microbiol. 45, 2787-2792 (2007). (Pubitemid 47417315)
34. Desai R, Ross LA, Hoffman JA. The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis. Pediatr. Infect. Dis. J. 28, 283-286 (2009).
35. Das SK, Bhattacharya S, Mitra K et al. Central nervous system fungal infection - a report of three cases. J. Indian. Med. Assoc. 102, 634-636 (2004).
36. Roilides E, Pavlidou E, Papadopoulos F et al. Cerebral aspergillosis in an infant with corticosteroid-resistant nephrotic syndrome. Pediatr. Nephrol. 18, 450-453 (2003). (Pubitemid 36798489)
37. Viscoli C, Machetti M, Gazzola P et al. Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J. Clin. Microbiol. 40, 1496-1499 (2002). (Pubitemid 34279924)
38. Kedzierska A, Kochan P, Pietrzyk A, Kedzierska J. Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1→3)-b-dglucan antigens. Eur. J. Clin. Microbiol. Infect. Dis. 26, 755-766 (2007). (Pubitemid 47573385)
39. Alexander BD, Pfaller MA. Contemporary tools for the diagnosis and management of invasive mycoses. Clin. Infect. Dis. 43, 15-27 (2006).
40. Odabasi Z, Mattiuzzi G, Estey E et al. b-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39, 199-205 (2004). (Pubitemid 38971490)
41. Miyazaki T, Kohno S, Mitsutake K et al. Plasma (1→3)-b-d-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J. Clin. Microbiol. 33, 3115-3118 (1995). (Pubitemid 3004590)
42. Senn L, Robinson JO, Schmidt S et al. 1,3-b-d-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin. Infect. Dis. 46, 878-885 (2008). (Pubitemid 351417190)
43. Presterl E, Parschalk B, Bauer E, Lassnigg A, Hajdu S, Graninger W. Invasive fungal infections and (1,3)-b-d-glucan serum concentrations in long-term intensive care patients. Int. J. Infect. Dis. 13, 707-712 (2009).
44. Racil Z, Kocmanova I, Lengerova M et al. Difficulties in using 1,3-{b}-d-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies - high frequency of false-positive results and their analysis. J. Med. Microbiol. 59, 1016-1022 (2010).
45. Ostrosky-Zeichner L, Alexander BD, Kett DH et al. Multicenter clinical evaluation of the (1,3)- b-d-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis. 41, 654-659 (2005). (Pubitemid 41170353)
46. Smith PB, Benjamin DK Jr, Alexander BD, Johnson MD, Finkelman MA, Steinbach WJ. Quantification of 1,3-b-dglucan levels in children: preliminary data for diagnostic use of the b-glucan assay in a pediatric setting. Clin. Vaccine Immunol. 14, 924-925 (2007).
47. Mokaddas E, Burhamah MH, Khan ZU, Ahmad S. Levels of (1→3)-b-d- glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species. BMC Infect. Dis. 10, 292 (2010).
48. Mularoni A, Furfaro E, Faraci M et al. High levels of b-d-glucan in immunocompromised children with proven invasive fungal disease. Clin. Vaccine Immunol. 17, 882-883 (2010).
49. Zhao L, Tang JY, Wang Y et al. Value of plasma b-glucan in early diagnosis of invasive fungal infection in children. Zhongguo Dang Dai Er Ke Za Zhi. 11, 905-908 (2009).
50. Ellis M, Al-Ramadi B, Finkelman M et al. Assessment of the clinical utility of serial b-d-glucan concentrations in patients with persistent neutropenic fever. J. Med. Microbiol. 57, 287-295 (2008). (Pubitemid 351358531)
51. Pazos C, Ponton J, Del Palacio A. Contribution of (1→3)-b-d-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J. Clin. Microb. 43, 299-305 (2005). (Pubitemid 40096315)
52. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1→3)-b-d-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol. 43, 5957-5962 (2005). (Pubitemid 43100644)
53. Desmet S, Van Wijngaerden E, Maertens J et al. Serum (1→3)-b-d- glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J. Clin. Microb. 47, 3871-3874 (2009).
54. Watanabe, T, Yasuoka, A, Tanuma J et al. Serum (1→3) b-D glucan as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS. Clin. Infect. Dis. 49, 1128-1131 (2009).
55. Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR. Reactivity of (1→3)-b-d-glucan assay with commonly used intravenous antimicrobials. Antimicrob. Agents Chemother. 50, 3450-3453 (2006). (Pubitemid 44527523)
56. Usami M, Ohata A, Horiuchi T, Nagasawa K, Wakabayashi T, Tanaka S. Positive (1→3)-b-d-glucan in blood components and release of (1→3)-b-d-glucan from depthtype membrane filters for blood processing. Transfusion 42, 1189-1195 (2002).
57. Koo S, Bryar JM, Page JH, Baden LR, Marty FM. Diagnostic performance of the (1→3)-b-d-glucan assay for invasive fungal disease. Clin. Infect. Dis. 49, 1650-1659 (2009).
58. Petraitiene R, Petraitis V, Hope WW et al. Cerebrospinal fluid and plasma (1→3)-d-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis. Antimicrob. Agents Chemother. 52, 4121-4129 (2008).
59. Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, Poulain D. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J. Clin. Microbiol. 37, 1510-1517 (1999). (Pubitemid 29187827)
60. Sendid B, Poirot JL, Tabouret M et al. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J. Med. Microbiol. 51, 433-442 (2002). (Pubitemid 34450601)
61. Alam FF, Mustafa AS, Khan ZU. Comparative evaluation of (1, 3)-b-dglucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect. Dis. 7, 103-112 (2007).
62. Verduyn Lunel FM, Donnelly JP, van der Lee HA, Blijlevens NM, Verweij PE. Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy. Clin. Microbiol. Infect. 15, 380-386 (2009).
63. Rimek D, Redetzke K, Singh J, Heinrich K, Kappe R. Performance of the Candida mannan antigen detection in patients with fungemia. Mycoses 47, 23-26 (2004). (Pubitemid 39573964)
64. Oliveri S, Trovato L, Betta P, Romeo MG, Nicoletti G. Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients. Clin. Microbiol. Infect. 14, 391-393 (2008). (Pubitemid 351356534)
65. Verduyn Lunel FM, Voss A, Kuijper EJ et al. Detection of the Candida antigen mannan in cerebrospinal fluid specimens from patients suspected of having Candida meningitis. J. Clin. Microbiol, 42, 867-870 (2004). (Pubitemid 38222684)
66. Kurita H, Kamata T, Zhao C, Narikawa JN, Koike T, Kurashina K. Usefulness of a commercial enzyme-linked immunosorbent assay kit for Candida mannan antigen for detecting Candida in oral rinse solutions. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 107, 531-534 (2009).
67. Lass-Flörl C, Gunsilius E, Gastl G et al. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J. Clin. Microbiol. 42, 4154-4157 (2004). (Pubitemid 39296138)
68. Tuon FF. A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev. Iberoam. Micol. 24, 89-94 (2007). (Pubitemid 47025141)
69. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect. Dis. 9, 89-96 (2009).
70. Khlif M, Mary C, Sellami H et al. Evaluation of nested and realtime PCR assays in the diagnosis of candidaemia. Clin. Microbiol. Infect. 15, 656-661 (2009).
71. von Lilienfeld-Toal M, Lehmann LE, Raadts AD et al. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J. Clin. Microbiol. 47, 2405-2410 (2009).
72. Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J. Clin. Microbiol. 42, 5517-5522 (2004). (Pubitemid 39664330)
73. White PL, Barton R, Guiver M et al. Aconsensus on fungal polymerase chain reaction diagnosis?: a United Kingdom- Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections. J. Mol. Diagn. 8, 376-384 (2006). (Pubitemid 44063816)
74. Khan ZU, Ahmad S, Theyyathel AM. Detection of Aspergillus fumigatus-specific DNA, (1-3)-b-d-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally infected rats. Mycoses 51, 129-135 (2008). (Pubitemid 351191118)
75. El-Mahallawy HA, Shaker HH, Ali Helmy H, Mostafa T, Razak Abo-Sedah A. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients. Med. Mycol. 44, 733-739 (2006). (Pubitemid 44824451)
76. Scotter JM, Campbell P, Anderson TP, Murdoch DR, Chambers ST, Patton WN. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis. Pathology 37, 246-253 (2005). (Pubitemid 40942988)
77. Jordanides NE, Allan EK, McLintock LA et al. A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haematooncology patients. Bone Marrow Transplant. 35, 389-395 (2005). (Pubitemid 40309485)
78. White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin. Infect. Dis. 42, 479-486 (2006). (Pubitemid 43202519)
79. Cesaro S, Stenghele C, Calore E et al. Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with oncohaematological diseases. Mycoses 51, 497-504 (2008).
80. Badiee P, Kordbacheh P, Alborzi A, Ramzi M, Shakiba E. Molecular detection of invasive aspergillosis in hematologic malignancies. Infection 36, 580-584 (2008).
81. Badiee P, Alborzi A, Shakiba E, Ziyaeyan M, Pourabbas B. Molecular diagnosis of Aspergillus endocarditis after cardiac surgery. J. Med. Microbiol. 58, 192-195 (2009).
82. Hummel M, Spiess B, Roder J et al. Detection of Aspergillus DNA by a nested PCR assay is able to improve the diagnosis of invasive aspergillosis in paediatric patients. J. Med. Microbiol. 58, 1291-1297 (2009).